If you do enough research, you'd be able to possibly find a few good smallcap gems that are trading at an undemanding valuation.
MYE and CLV are two that I have come across.
The table below seeks to compare their relative valuation and their financial metrics. Both LVT and BUD annual revenues tweaked to include post-acquisition outcomes (estimate). Both LVT and BUD recent acquisitions only serve to make their MC higher at present prices (meaning their sp would need to adjust downwards going forwards) and at such lofty valuations, you can even get growing businesses like MYE and CLV that are already profitable and with established revenue bases.
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
Column 7
Column 8
0
Shares
Price
Mkt Cap
Ann Revenue
MC/Rev
Profit/(Loss) (m)
1
LIVETILES
607.952
$ 0.355
$215.82
$13.69
15.77
-$ 22.06
2
BUDDY PLATFORM
1,797.05
$ 0.082
$147.36
$42.08
3.50
-$ 13.88
3
CATAPULT
206.023
$0.66
$134.95
$86.00
1.57
-$ 16.20
4
MASTERMYNE (MYE)
101.10
$ 0.885
$ 89.47
$ 201.72
0.44
$ 5.59
5
YOJEE
950.61
$ 0.076
$ 72.25
$ 0.42
170.39
-$ 5.69
6
CLOVER (CLV)
166.31
$ 1.590
$264.43
$62.56
4.23
$ 7.59
I know some would say you cant compare them as they are different businesses. Look - at the end of the day, it wont matter if you sell a state of the art tech or underwears, its your profits and cashflows that count. And if you haven't got them yet (I used yet because it is the yet that is underpinning MC of stocks like BUD/LVT/YOJ) then it is overvalued for its progress to date.
